New rules aim to curb insurance brokers and protect consumers; data highlights surge in post-pandemic hospital-onset infections; President Biden’s decision to step down highlights Harris’ stance on health care reform and equity.
Biden Administration Enacts Measures to Prevent Unauthorized ACA Plan Changes
In response to increasing complaints, the Biden administration has implemented strict regulations to prevent unauthorized changes to Affordable Care Act (ACA) plans by insurance brokers, according to Kaiser Health News. The new rules, effective immediately, require brokers to prove their association with a consumer’s policy before making any changes. This move is intended to safeguard consumers from unexpected plan switches and potential financial repercussions.
Infectious Disease Experts Urge for Increased Federal Funding Amid Rising Antimicrobial Resistance in Hospitals
Infectious disease professionals are calling for greater federal funding following new CDC data showing an increase in antimicrobial-resistant pathogens in hospitals, according to Fierce Healthcare. From 2019 to 2022, 6 out of 7 monitored infections have become more prevalent, with Candida auris cases rising almost five-fold. The Society for Healthcare Epidemiology of America emphasized the need for sustained investments in infection control and prevention strategies, especially considering a recent House bill proposing significant cuts to CDC funding.
Kamala Harris Emerges as Leader on Health Policy Amid Presidential Endorsement
Vice President Kamala Harris has been a prominent advocate for President Biden's health initiatives, including maternal health improvements and the ACA, according to Managed Healthcare Executive®. With Biden announcing he won't seek re-election and endorsing Harris as the Democratic nominee, her health care views gain significant importance. Harris's leadership on extending postpartum Medicaid coverage and her staunch support for abortion rights underscore her commitment to health equity and access for all Americans.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Robert F. Kennedy Jr Faces Senate Inquiry Over Deep Cuts to HHS Impacting FDA, CDC, NIH, CMS
April 2nd 2025A bipartisan letter from lawmakers questions the legality of Robert F. Kennedy Jr's HHS changes and the lack of clear communication regarding their potential impact on American health.
Read More
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More